Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
NeuroBo Pharmaceuticals (NRBO) has issued an announcement.
NeuroBo Pharmaceuticals, Inc. has joined forces with Dong-A ST Co. Ltd. and ImmunoForge to create a new long-acting, once-monthly drug formulation for DA-1726, a promising dual-action diabetes treatment. This collaboration will leverage ImmunoForge’s innovative ELP technology to extend the medication’s active life. While this news is promising, the company cautions that these forward-looking statements are not assured and actual outcomes may vary.
For a thorough assessment of NRBO stock, go to TipRanks’ Stock Analysis page.
